Journal of Biomedical Research
Open Access
Double Blind
Bimonthly
18% acceptance rate
Peer Review
Double Blind
OA Type
Gold OA
Acceptance
18%
Time to Decision
6 weeks
Frequency
Bimonthly
APC
2,200 USD
Impact Factor (2023)
4.2
CiteScore (2023)
6.1
H-index (2023)
58
About This Journal
The Journal of Biomedical Research is a leading peer-reviewed publication dedicated to advancing knowledge across the full spectrum of biomedical science. Since its founding, the journal has served as a critical bridge between laboratory discovery and clinical translation, publishing original research articles, comprehensive reviews, and rapid communications that shape modern medicine. Articles span molecular and cellular biology, physiology, pharmacology, immunology, genetics, and translational medicine.
Aims & Scope
The journal's scope encompasses:
• Molecular and cellular biology: signal transduction, gene expression, and cell cycle regulation
• Translational and clinical research bridging bench discoveries to patient outcomes
• Immunology, infectious diseases, and vaccine development
• Cancer biology, oncology, and tumour microenvironments
• Cardiovascular, metabolic, and neurological disease mechanisms
• Pharmacology, drug discovery, and precision medicine
• Biomarker identification and diagnostic development
The journal particularly welcomes studies employing single-cell sequencing, CRISPR-based approaches, proteomics, and advanced imaging. Interdisciplinary research integrating computational and experimental approaches is strongly encouraged.
• Molecular and cellular biology: signal transduction, gene expression, and cell cycle regulation
• Translational and clinical research bridging bench discoveries to patient outcomes
• Immunology, infectious diseases, and vaccine development
• Cancer biology, oncology, and tumour microenvironments
• Cardiovascular, metabolic, and neurological disease mechanisms
• Pharmacology, drug discovery, and precision medicine
• Biomarker identification and diagnostic development
The journal particularly welcomes studies employing single-cell sequencing, CRISPR-based approaches, proteomics, and advanced imaging. Interdisciplinary research integrating computational and experimental approaches is strongly encouraged.